1 MONTELUKAST SODIUM | 80 of 1080 | 3430 prescriptions Less than 1% of all prescriptions | 2580 | 930 patients 27% of all patients | 730 patients 21% of all patients | |
2 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 190 of 1240 | 1530 prescriptions Less than 1% of all prescriptions | 1150 | 470 patients 14% of all patients | < 11 | |
3 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 90 of 1050 | 1820 prescriptions Less than 1% of all prescriptions | 1690 | 490 patients 14% of all patients | < 11 | |
4 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 200 of 1080 | 1530 prescriptions Less than 1% of all prescriptions | 1080 | 430 patients 13% of all patients | 310 patients 9% of all patients | |
5 PREDNISONE | 160 of 1220 | 2030 prescriptions Less than 1% of all prescriptions | 1310 | 930 patients 27% of all patients | 700 patients 21% of all patients | |
6 SPIRIVA (TIOTROPIUM BROMIDE) | 170 of 1050 | 910 prescriptions Less than 1% of all prescriptions | 510 | 230 patients 7% of all patients | < 11 | |
7 VENTOLIN HFA (ALBUTEROL SULFATE) | 280 of 1260 | 1260 prescriptions Less than 1% of all prescriptions | 720 | 530 patients 16% of all patients | 340 patients 10% of all patients | |
8 PROAIR HFA (ALBUTEROL SULFATE) | 130 of 1130 | 1410 prescriptions Less than 1% of all prescriptions | 810 | 630 patients 18% of all patients | 440 patients 13% of all patients | |
9 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 250 of 960 | 800 prescriptions Less than 1% of all prescriptions | | 240 patients 7% of all patients | < 11 | |
10 DALIRESP (ROFLUMILAST) | 30 of 470 | 760 prescriptions Less than 1% of all prescriptions | 570 | 190 patients 6% of all patients | < 11 | |
11 AZITHROMYCIN | 110 of 960 | 1220 prescriptions Less than 1% of all prescriptions | 1050 | 510 patients 15% of all patients | 400 patients 12% of all patients | A |
12 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 320 of 980 | 630 prescriptions Less than 1% of all prescriptions | 450 | 140 patients 4% of all patients | < 11 | |
13 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 80 of 530 | 620 prescriptions Less than 1% of all prescriptions | | 300 patients 9% of all patients | < 11 | |
14 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 450 of 1070 | 430 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 110 of 620 | 380 prescriptions Less than 1% of all prescriptions | | 140 patients 4% of all patients | < 11 | |
16 THEOPHYLLINE ANHYDROUS | 30 of 180 | 460 prescriptions Less than 1% of all prescriptions | 350 | < 11 | < 11 | |
17 IPRATROPIUM BROMIDE | 60 of 220 | 420 prescriptions Less than 1% of all prescriptions | 260 | 190 patients 6% of all patients | < 11 | |
18 FLOVENT HFA (FLUTICASONE PROPIONATE) | 190 of 430 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 FLUTICASONE PROPIONATE | 500 of 890 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 300 of 630 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
21 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 40 of 200 | 230 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 SEREVENT DISKUS (SALMETEROL XINAFOATE) | 60 of 140 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
23 AZELASTINE HCL | 210 of 330 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 DULERA (MOMETASONE/FORMOTEROL) | 120 of 220 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 AZATHIOPRINE | 30 of 90 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 UTIBRON NEOHALER (INDACATEROL/GLYCOPYRROLATE) | 10 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
27 MIRTAZAPINE | 80 of 100 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
28 NYSTATIN | 60 of 70 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
29 DOXYCYCLINE HYCLATE | 120 of 230 | 150 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | A |